Cargando…

Brucella β 1,2 Cyclic Glucan Is an Activator of Human and Mouse Dendritic Cells

Bacterial cyclic glucans are glucose polymers that concentrate within the periplasm of alpha-proteobacteria. These molecules are necessary to maintain the homeostasis of the cell envelope by contributing to the osmolarity of Gram negative bacteria. Here, we demonstrate that Brucella β 1,2 cyclic glu...

Descripción completa

Detalles Bibliográficos
Autores principales: Martirosyan, Anna, Pérez-Gutierrez, Camino, Banchereau, Romain, Dutartre, Hélène, Lecine, Patrick, Dullaers, Melissa, Mello, Marielle, Pinto Salcedo, Suzana, Muller, Alexandre, Leserman, Lee, Levy, Yves, Zurawski, Gerard, Zurawski, Sandy, Moreno, Edgardo, Moriyón, Ignacio, Klechevsky, Eynav, Banchereau, Jacques, Oh, SangKon, Gorvel, Jean-Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499565/
https://www.ncbi.nlm.nih.gov/pubmed/23166489
http://dx.doi.org/10.1371/journal.ppat.1002983
Descripción
Sumario:Bacterial cyclic glucans are glucose polymers that concentrate within the periplasm of alpha-proteobacteria. These molecules are necessary to maintain the homeostasis of the cell envelope by contributing to the osmolarity of Gram negative bacteria. Here, we demonstrate that Brucella β 1,2 cyclic glucans are potent activators of human and mouse dendritic cells. Dendritic cells activation by Brucella β 1,2 cyclic glucans requires TLR4, MyD88 and TRIF, but not CD14. The Brucella cyclic glucans showed neither toxicity nor immunogenicity compared to LPS and triggered antigen-specific CD8(+) T cell responses in vivo. These cyclic glucans also enhanced antigen-specific CD4(+) and CD8(+) T cell responses including cross-presentation by different human DC subsets. Brucella β 1,2 cyclic glucans increased the memory CD4(+) T cell responses of blood mononuclear cells exposed to recombinant fusion proteins composed of anti-CD40 antibody and antigens from both hepatitis C virus and Mycobacterium tuberculosis. Thus cyclic glucans represent a new class of adjuvants, which might contribute to the development of effective antimicrobial therapies.